Physiological vs Right Ventricular Pacing Outcome Trial Evaluated for bradyCardia Treatment (PROTECT-HF)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2600 participants.

Also called NCT05815745

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 2,600 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05815745
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Ireland, Slovenia, United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05815745. Randomized; double masking; primary purpose treatment. Start 2023-06-05 (actual); primary completion 2031-06-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
"Physiological vs Right Ventricular Pacing Outcome Trial Evaluated for bradyCardia Treatment" (PROTECT-HF)
Acronym
PROTECT-HF
Condition
Bradycardia
Condition
Pacing
Condition
Right Ventricular Pacing
Condition
His Bundle Pacing
Condition
Left Bundle Branch Area Pacing
Intervention (Device)
Pacemaker - Physiological pacing
Intervention (Device)
Pacemaker - Right Ventricular pacing
Lead sponsor
Imperial College London (class: other)
Collaborator
British Heart Foundation (class: other)

Record details

Record id
cardio:ct-nct05815745
Content hash
403c113a7372c48e6756dae77d41d6a71b3164cbe4282277a299bd8167a9c751